Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma
卡铂联合厄洛替尼（Tarceva，OSI-774）治疗复发性胶质母细胞瘤患者的II期研究
期刊:Journal of Neuro-Oncology
影响因子:3.1
doi:10.1007/s11060-008-9637-y
de Groot, J F; Gilbert, M R; Aldape, K; Hess, K R; Hanna, T A; Ictech, S; Groves, M D; Conrad, C; Colman, H; Puduvalli, V K; Levin, V; Yung, W K A
